Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers R > Headlines for Regeneron Pharmaceuticals Inc. > News item |
Regeneron plans follow-on sale of 7.6 million shares via Morgan Stanley
By Ronda Fears
Memphis, Nov. 13 - Regeneron Pharmaceuticals, Inc. announced Monday plans to sell 7.6 million shares of common stock in a follow-on offering via bookrunner Morgan Stanley & Co. Inc.
Tarrytown, N.Y.-based Regeneron is focused on drugs for cancer, eye diseases and inflammatory diseases.
Regeneron shares (Nasdaq: REGN) closed Monday higher by 46 cents, or 1.93%, at $24.28. In after-hours activity the stock was down by 68 cents, or 2.8%, and last seen, at 5:39 p.m. ET at $23.60.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.